EQS-News: Sartorius releases Annual Report for 2023
Source: EQS
Göttingen,
Sartorius releases Annual Report for 2023 The life science group Sartorius has released its Annual Report for 2023 today. The document is available under the following link: https://ir-reports.sartorius.com/en/ag/fy-2023. Financial calendar A profile of Sartorius Sartorius is a leading international partner of life sciences research and biopharmaceutical manufacturing. With innovative laboratory instruments and consumables, the Group’s Lab Products & Services division focuses on laboratories performing research and quality control at pharmaceutical and biopharmaceutical companies as well as academic research institutes. The Bioprocess Solutions division, with its broad product portfolio focusing on single-use solutions, helps customers manufacture biotech medications, vaccines, and cell and gene therapies safely, rapidly, and economically. The company, based in Göttingen, Contact +49 (0)551.308.4724 timo.lindemann@sartorius.com Follow Sartorius on LinkedIn. Additional features: File: Press Release
|
Language: | English |
Company: | |
Otto-Brenner-Straße 20 | |
37079 Göttingen | |
Phone: | +49.(0)551-308.0 |
Fax: | +49.(0)551-308.3289 |
E-mail: | info@sartorius.com |
Internet: | www.sartorius.com |
ISIN: | DE0007165607, DE0007165631 |
WKN: | 716560 , 716563 |
Indices: | DAX, TecDAX |
Listed: | Regulated Market in |
EQS News ID: | 1838357 |
End of News |
|
1838357 16.02.2024 CET/CEST